Clinical Trial Update: Treatment of Metastatic Melanoma With Tumor Infiltrating Lymphocytes and IL-2 Following Lympho-depleting Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating tumor-infiltrating lymphocytes plus IL-2 after lymphodepleting chemotherapy in metastatic melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Metastatic Melanoma | Phase 2 | Status: UNKNOWN